Загрузка...
Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
There remains an unmet need for effective, well-tolerated therapeutic options in paediatric patients with not fully controlled asthma, for whom safety is of paramount importance. Data were pooled from five randomised, double-blind, placebo-controlled studies evaluating tiotropium 5 or 2.5 µg versus...
Сохранить в:
| Опубликовано в: : | Eur Respir J |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
European Respiratory Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581158/ https://ncbi.nlm.nih.gov/pubmed/31097514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01824-2018 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|